Tumor cells expressing TLR4 are linked to decreased recurrence rates, while fibroblasts expressing TLR4 are independently associated with higher recurrence rates and shorter overall survival, suggesting fibroblast TLR4 expression as a prognostic marker in CRC [104]. Here, TLR4 is linked to neoplasm.